Skip to main content

Table 1 Uni– and multivariate analyses including TNM, sex, age, location, CEA, grade, Deep-TSR score, Deep-TIL score, and Deep-immune score for OS in the two cohorts

From: Artificial intelligence for quantifying immune infiltrates interacting with stroma in colorectal cancer

 

Univariate analysis

Multivariate analysis

 

Primary cohort

Validation cohort

Primary cohort

Validation cohort

 

HR (95% CI)

P

HR (95% CI)

P

HR (95% CI)

P

HR (95% CI)

P

TNM

        

I

1

 

1

 

1

 

1

 

II

2.48 (1.12–5.50)

0.025

1.53 (0.54–4.34)

0.400

2.56 (1.01–6.51)

0.048

1.14 (0.39–3.36)

0.800

III

6.17 (2.87–13.3)

 < 0.001

3.94 (1.44–10.8)

0.008

5.78 (2.33–14.4)

 < 0.001

2.70 (0.94–7.79)

0.066

Sex

        

Male

1

 

1

     

Female

1.05 (0.71–1.56)

0.800

0.78 (0.33–1.84)

0.600

    

Age

1.03 (1.01–1.04)

 < 0.001

1.03 (1.01–1.04)

0.001

1.03 (1.01–1.04)

 < 0.001

1.03 (1.01–1.04)

 < 0.001

Location

        

Colon

1

 

1

     

Rectum

1.00 (0.73–1.37)

0.999

1.48 (1.00–2.21)

0.053

    

CEA

        

Normal

1

 

1

 

1

 

1

 

Abnormal

2.58 (1.87–3.56)

 < 0.001

1.98 (1.35–2.91)

 < 0.001

1.94 (1.40–2.70)

 < 0.001

1.46 (0.46–1.18)

0.200

Grade

        

Low

1

 

1

     

High

1.44 (0.91–2.28)

0.120

1.80 (1.22–2.67)

0.003

    

Deep-TSR score

        

High

1

 

1

     

Low

0.62 (0.45–0.86)

0.004

0.57 (0.38–0.85)

0.005

    

Deep-TIL score

        

Low

1

 

1

     

Middle

0.69 (0.48–0.99)

0.044

0.73 (0.46–1.17)

0.200

    

High

0.45 (0.30–0.67)

 < 0.001

0.49 (0.31–0.77)

0.002

    

Deep-immune score

        

1

1

 

1

 

1

 

1

 

2

0.68 (0.43–1.08)

0.100

0.72 (0.45–1.14)

0.200

0.67 (0.42–1.10)

0.110

0.73 (0.46–1.18)

0.200

3

0.48 (0.30–0.77)

0.002

0.48 (0.29–0.79)

0.004

0.54 (0.33–0.90)

0.019

0.64 (0.38–1.07)

0.091

4

0.27 (0.15–0.48)

 < 0.001

0.31 (0.15–0.62)

 < 0.001

0.36 (0.20–0.66)

0.001

0.41 (0.20–0.84)

0.016

  1. TNM, tumor-node-metastasis; CEA, carcinoembryonic antigen; TSR, tumor-stroma ratio; TIL, tumor-infiltrating lymphocytes; OS, overall survival; HR, Hazard ratio; CI, confidence interval